Bickii J, Basco L K, Ringwald P
Institut Français de Recherche Scientifique pour le Développement en Coopération (ORSTOM) and Laboratoire de Recherches sur le Paludisme, Organisation de Coordination pour la Lutte contre les Endémies en Afrique Centrale, Yaoundé, Cameroon.
J Clin Microbiol. 1998 Jan;36(1):243-7. doi: 10.1128/JCM.36.1.243-247.1998.
Three in vitro assays (the isotopic semimicrotest [700 microl per well; 24-well plates], the isotopic microtest [200 microl per well; 96-well plates], and the rapid in vitro test) and the standard in vivo test for chloroquine resistance were compared for 99 clinical isolates of Plasmodium falciparum obtained from symptomatic African patients. The 50% inhibitory concentrations determined by the two isotopic tests were similar and were highly correlated (r = 0.965; P < 0.05), showing a high concordance between the semimicrotest and the microtest. There was a moderate agreement between these two isotopic tests and the in vivo test. Most of the discordant results were probably due to host factors, including reinfections, pharmacokinetic variations, and immunologic response, which are eliminated in in vitro assays. The rapid in vitro test based on the inhibition of chloroquine efflux in the presence of verapamil was poorly concordant with the other tests. Despite some discordant results, isotopic in vitro assays are useful to characterize the phenotypes of individual isolates without the interference of host factors and are complementary to in vivo evaluation of drug efficacy. However, in vitro assays need to be standardized to allow direct comparison of results between different laboratories.
对从有症状的非洲患者中获得的99株恶性疟原虫临床分离株,比较了三种体外试验(同位素半微量试验[每孔700微升;24孔板]、同位素微量试验[每孔200微升;96孔板]和快速体外试验)以及氯喹抗性的标准体内试验。两种同位素试验测定的50%抑制浓度相似且高度相关(r = 0.965;P < 0.05),表明半微量试验和微量试验之间具有高度一致性。这两种同位素试验与体内试验之间存在中度一致性。大多数不一致的结果可能归因于宿主因素,包括再感染、药代动力学变化和免疫反应,而这些因素在体外试验中被消除。基于维拉帕米存在下氯喹外排抑制的快速体外试验与其他试验的一致性较差。尽管存在一些不一致的结果,但同位素体外试验有助于在无宿主因素干扰的情况下表征单个分离株的表型,并且是药物疗效体内评估的补充。然而,体外试验需要标准化,以便不同实验室之间能够直接比较结果。